Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agile Therapeutics Inc (NQ: AGRX )

0.6022 UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.6022
Bid (Size) 0.2400 (9)
Ask (Size) 0.2407 (5)
Prev. Close 0.6022
Today's Range 0.6022 - 0.6022
52wk Range 0.5040 - 7.000
Shares Outstanding 6,856,229
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Misses Revenue for Q4 2023
AGRX stock results show that Agile Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Agile Therapeutics: Q4 Earnings Insights
Via Benzinga

Performance

YTD
-67.27%
-67.27%
1 Month
+14.14%
+14.14%
3 Month
-61.89%
-61.89%
6 Month
-67.97%
-67.97%
1 Year
-90.97%
-90.97%

More News

Read More
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
From Agile Therapeutics, Inc.
Via GlobeNewswire
Agile Therapeutics's Earnings: A Preview
Via Benzinga
Why Agile Therapeutics (AGRX) Stock Is Down 60%
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Agile Therapeutics's Earnings: A Preview
Via Benzinga
Agile Therapeutics Announces Delisting from Nasdaq
From Agile Therapeutics, Inc.
Via GlobeNewswire
Earnings Scheduled For March 22, 2024
Via Benzinga
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
From Agile Therapeutics, Inc.
Via GlobeNewswire
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
From Agile Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
From Agile Therapeutics, Inc.
Via GlobeNewswire
What's Going On With Women Health Focused Agile Therapeutics Stock Today?
Via Benzinga
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
From Agile Therapeutics, Inc.
Via GlobeNewswire
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Is Bel Fuse (BELFB) Stock Down 17% Today?
Via InvestorPlace
Why Is Draganfly (DPRO) Stock Down 48% Today?
Via InvestorPlace
Why Is BuzzFeed (BZFD) Stock Up 101% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Is Agile Therapeutics (AGRX) Stock Up 87% Today?
Via InvestorPlace
Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
5 Value Stocks In The Healthcare Sector
Via Benzinga
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
From Agile Therapeutics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.